The Fourth Annual Wharton New Ventures in Healthcare Conference, to be held April 8 and 9 at the Wyndham Franklin Plaza Hotel, examines "the critical issues confronting technology-based life sciences companies" and expects to generate debate among industry leaders from the biotechnology, pharmaceutical, and medical device sectors, planners said.
Keynote speakers include Dr. John W. Holaday, chairman, president and CEO of EntreMed, Inc., and James L. Vincent, chairman and CEO of Biogen, Inc., recipient of the Inaugural NVHC Achievement Award.
Dr. Patricia Danzon, Celia Moh Professor of Health Care Systems, Insurance & Risk Management, will moderate a session on Pricing Pressure for New Product Technologies.
Wharton MBA students organized the conference with the help of a Conference Advisory Board that is established each year to help define the conference agenda.
The deadline to register is March 26. Fees, which are non-refundable and include cocktail reception, breakfast and lunch, are: Student/partner: $20; Penn faculty/staff, Wharton Alumni: $100; Executives and other industry professionals: $150. Checks payable to "WGA -NVHC" can mailed to:Wharton MBA Health Care Program c/o Ms. June Kinney Room 205, Colonial Penn Center 3641 Locust Walk Philadelphia, PA 19104-2618
For further information call (215) 573-4877.
Almanac, Vol. 45, No. 24, March 16, 1999